News Archive - Seek Labs

October 23, 2025

Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation

Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation At Seek Labs, every day is World CRISPR Day. Our work in programmable therapeutics builds upon the same principles that make CRISPR so revolutionary: precision, adaptability, and speed. As we reflect on this transformative technology, we’re not just looking at…

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™

Featured, News, Press Release, Therapeutics

October 21, 2025

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™ October 21, 2025 Salt Lake City, UT (Business Wire)–Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery programmable therapeutics, and point-of-care diagnostics, today announced an expansion of its Global Disease Atlas™ to include multiple hemorrhagic fever viruses.…

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

Featured, News, Press Release, Therapeutics

October 7, 2025

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™ October 7, 2025 BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family. Early in vitro testing of the BioSeeker-developed therapeutic construct achieved up to 90% viral knockdown in a vaccinia virus model, laying the…

Seek Labs VP of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award

Diagnostics, Featured, News

October 6, 2025

Seek Labs VP of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award

Seek Labs Vice President of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award October 6, 2025 Seek Labs is proud to announce our Vice President of Research, Dr. Anindita “Annie” Roy, has been selected as the Rising Star Award recipient by the Women Tech Council as part of the 2025…

Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)

Corporate, Featured, News

September 23, 2025

Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)

Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV) September 24, 2025 Salt Lake City, UT (Business Wire) – Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, announced today that it has joined two federally supported…

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™

Featured, News, Therapeutics

September 9, 2025

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic September 9, 2025 Salt Lake City, UT (Business Wire) – Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the inclusion of Foot-and-Mouth Disease (FMD) in its BioSeeker™ Global…

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

Diagnostics, Featured, News

August 13, 2025

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform Built in a matter of months, Seek Labs’ functional investigational prototype delivers point-of-care Mycobacterium tuberculosis detection without instrumentation, electricity, or lab infrastructure. August 13, 2025 View the SeekIt for MTB Poster here Salt Lake City, UT, August 13, 2025 (Business Wire) —…

Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™

Featured, News, Therapeutics

August 5, 2025

Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™

Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™, Accelerating Therapeutic Discovery for Chikungunya, West Nile Virus, and Zika August 5, 2025 Salt Lake City, UT, August 5, 2025 (Business Wire) — Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the successful mapping…

We Can’t Feed the World If We Ignore Animal Disease: Why Veterinary Pathogens Are a Global Health Crisis

Blog

July 23, 2025

We Can’t Feed the World If We Ignore Animal Disease: Why Veterinary Pathogens Are a Global Health Crisis

We Can’t Feed the World If We Ignore Animal Disease: Why Veterinary Pathogens Are a Global Health Crisis According to the WHO, 60% of emerging infectious diseases are zoonotic. And those risks are rising as deforestation and climate shifts push animals closer to humans. By Jared bauer, Ceo of Seek Labs | July 23, 2025…

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas

Featured, News, Therapeutics

July 22, 2025

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains July 22, 2025 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the inclusion of veterinary…

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

Corporate, Featured, News, Therapeutics

July 8, 2025

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) July 8, 2025 Read the Medium Article from our CEO, Jared Bauer, about the Urgent Need to Fight RSV Globally. Salt Lake City, UT (Business Wire) — Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and…

RSV Isn’t Just a Cold — It’s a Global Crisis We Keep Ignoring

Blog

July 8, 2025

RSV Isn’t Just a Cold — It’s a Global Crisis We Keep Ignoring

RSV Isn’t Just a Cold; It’s a Global Crisis We Keep Ignoring Why RSV is more dangerous than people think and what we’re doing to change that By Jared Bauer, CEO of Seek Labs | july 8, 2025 In January, my wife got sick. Really sick. RSV, influenza, and pneumonia, all at once. She’s a healthy,…

All News

Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

Seek Labs VP of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award

Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™

We Can’t Feed the World If We Ignore Animal Disease: Why Veterinary Pathogens Are a Global Health Crisis

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

RSV Isn’t Just a Cold — It’s a Global Crisis We Keep Ignoring

Follow the work as it unfolds.